FundedIQ
Biotechnology

Gemelli Biotech: Funding, Investors & Team (Sep 2026)

Gemelli is a biotechnology organization that has practical experience in the microbiome, and IBS diagnostics. It endeavors to accomplish a flourishing worldwide group of solid people by opening the capability of the microbiome. The organization is driven by its central goal is to help the disclosure of novel diagnostics and therapeutics for the human microbiome by putting up biotechnology developments for sale to the public in a monetarily dependable and socially cognizant way. The organization was established in 2018 and settled in North Carolina, United States.

www.gemellibiotech.com LinkedIn Raleigh, United States 11-50 employees
Biotechnology Health Diagnostics Pharmaceutical B2C
Total raised
$19.0M
Rounds
1
Latest
Series A
Jun 2022

Gemelli Biotech has raised $19.0M across 1 funding round on record, the most recent a Series A of $19.0M announced in Jun 2022.

That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

Gemelli Biotech Company Profile and Key Stats

Total funding raised
$19.0M
across 1 round on record
Funding rounds on record
1
Latest funding round
Series A
$19.0M in Jun 2022
Employees
11-50
reported band
Headquarters
Raleigh, United States

Latest funding round on record: Jun 2022.

Gemelli Biotech Funding Rounds

Date
Round
Amount
Series A
$19.0M

Gemelli Biotech Founders and Leadership Team

Name
Role
Contact
Mark Pimentel
Founder
Locked

Contact details for the Gemelli Biotech team: 1 of 1 has an email address on file.

Start 14-day free trial →

Gemelli Biotech Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,179
$8.0M
29,722
$7.5M
8,352
$15M

Gemelli Biotech's latest round of $19.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like Gemelli Biotech in Biotechnology and Raleigh

Companies Similar to Gemelli Biotech

Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…

Convertible Note $6.8M

XiltriX North America is an information technology company that specializes in monitoring, predictive…

Undisclosed round $3.0M

Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…

Seed $3.1M

Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…

Series D $66.0M

Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…

Series B $92.7M

Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…

Series C $110M

InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…

Series B $77.0M

Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant…

Series A $6.3M

Legendary Bio's solidarity is a determined spotlight on introducing another period of quality guideline.

Series C $90.0M

Cataract surgery is the single most common procedure performed in the United States annually. Despite…

Series A $7.0M

InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and…

Convertible Note $1.3M

Remedium Bio is a gene therapy company in the Boston area that is dedicated to developing cures for severe…

Series A $10.0M

Gemelli Biotech Funding FAQs

What does Gemelli Biotech do?

Gemelli is a biotechnology organization that has practical experience in the microbiome, and IBS diagnostics. It endeavors to accomplish a flourishing worldwide group of solid people by opening the capability of the microbiome. The organization is driven by its central goal is to help the disclosure of novel diagnostics and therapeutics for the human microbiome by putting up biotechnology developments for sale to the public in a monetarily dependable and socially cognizant way. The organization was established in 2018 and settled in North Carolina, United States.

How much funding has Gemelli Biotech raised?

Gemelli Biotech has raised $19.0M across 1 round on record. The most recent is a Series A of $19.0M announced in Jun 2022.

When did Gemelli Biotech last raise funding?

Gemelli Biotech's most recent funding round on record is a Series A of $19.0M, announced in Jun 2022.

Who founded Gemelli Biotech?

FundedIQ lists Mark Pimentel (Founder) at Gemelli Biotech.

Where is Gemelli Biotech headquartered?

Gemelli Biotech is based in Raleigh, North Carolina, United States.

How many employees does Gemelli Biotech have?

Gemelli Biotech is in the 11-50 employee band.

How does Gemelli Biotech's funding compare to other Biotechnology startups?

Gemelli Biotech's latest round of $19.0M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.

About FundedIQ's Gemelli Biotech Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Gemelli Biotech is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.

Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.